FY2024 EPS Estimates for Ayr Wellness Decreased by Analyst

Ayr Wellness Inc. (OTCMKTS:AYRWF) – Research analysts at Atb Cap Markets lowered their FY2024 earnings estimates for shares of Ayr Wellness in a report released on Wednesday, November 13th. Atb Cap Markets analyst F. Gomes now forecasts that the company will post earnings per share of ($1.34) for the year, down from their prior estimate of ($1.15). Atb Cap Markets currently has a “Strong Sell” rating on the stock. The consensus estimate for Ayr Wellness’ current full-year earnings is ($1.30) per share. Atb Cap Markets also issued estimates for Ayr Wellness’ Q4 2024 earnings at ($0.29) EPS and FY2025 earnings at ($0.98) EPS.

Other equities research analysts have also issued research reports about the company. Roth Mkm lowered their target price on Ayr Wellness from $3.50 to $3.00 and set a “buy” rating for the company in a research note on Thursday, November 14th. Roth Capital upgraded Ayr Wellness to a “strong-buy” rating in a report on Friday, November 8th.

Ayr Wellness Price Performance

Shares of OTCMKTS AYRWF opened at $0.77 on Monday. The stock has a fifty day moving average price of $1.79 and a 200 day moving average price of $1.97. The company has a current ratio of 1.59, a quick ratio of 0.67 and a debt-to-equity ratio of 0.76. Ayr Wellness has a 12-month low of $0.71 and a 12-month high of $4.09. The company has a market cap of $87.90 million, a P/E ratio of -0.35 and a beta of 2.00.

Ayr Wellness Company Profile

Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.